Susceptibility of clinical isolates of Bordetella pertussis to chemicals

被引:0
|
作者
Uttlova, P. [1 ,2 ]
Urban, J. [1 ]
Melichercikova, V [1 ]
Zavadilova, J. [3 ]
Fabianova, K. [4 ]
机构
[1] Natl Inst Publ Hlth, Natl Reference Lab Disinfect & Sterilisat, Prague, Czech Republic
[2] Charles Univ Prague, Fac Med 3, Prague, Czech Republic
[3] Natl Inst Publ Hlth, Natl Reference Lab Pertussis & Diphtheria, Prague, Czech Republic
[4] Natl Inst Publ Hlth, Dept Infect Dis Epidemiol, Prague, Czech Republic
来源
关键词
Bordetella pertussis; susceptibility; disinfectants; BACTERIAL-RESISTANCE; DISINFECTANTS; TRICLOSAN;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The aim of study: To test clinical isolates of Bordetella pertussis from the National Reference Laboratory for Pertussis and Diphtheria for susceptibility to commonly available disinfectants. Another aim was to determine the concentration and exposure time for each chemical under real conditions of use and possibly to detect the emergence of resistance to disinfectants among 34 strains of B. pertussis referred to the National Reference Laboratory for Pertussis and Diphtheria in 2014 and 2015. Material and methods: A total of 34 clinical isolates of Bordetella pertussis were tested for susceptibility to chemical disinfectants by three different methods. The microsuspension method was used for the primary screening, and the tests were carried out without protein contamination. Further testing was conducted in accordance with standard EN 14885, where the test procedure consists of several steps. Step 1 involves quantitative suspension methods (Phase 2, Step 1), and step 2 uses methods designed for practice (Phase 2, Step 2). The quantitative suspension method modified according to EN 13727+A2 was used in step 1 to confirm bactericidal activity of the test products under the dirty conditions. In step 2, clinical isolates were tested using a quantitative carrier test method under the dirty conditions modified according to EN 14561. Based on this standard, the real conditions of product use are simulated. Four disinfectants differing in composition and intended use were tested. Results: Disinfectant No. 1 showed bactericidal activity at a concentration of 0.5% after 2 min of exposure in the case of immersion or at a concentration of 5% after 2 min of exposure when treated by wiping. Disinfectant No. 2 was active at a concentration of 0.1% after 2 min of exposure or at a concentration of 1% after 2 min of exposure, respectively. Disinfectant No. 3 did not show bactericidal activity even at a concentration of 100% after 5 min of exposure. Disinfectant No. 4 showed bactericidal activity at a concentration of 10% after 5 min of exposure or at a concentration of 30% after 2 min of exposure. Conclusions: None of the strains tested was resistant. Using the methods that simulate the real conditions of use of disinfectants Nos. 1 and 2, it was possible to determine the concentration and exposure time needed to achieve disinfection of surfaces under the dirty conditions. Disinfectants Nos. 3 and 4 are not primarily intended for the treatment of surfaces but for the treatment of the skin and mucous membranes. The results obtained with the latter two products are interesting but inconclusive as the real conditions of their use were not simulated accurately.
引用
收藏
页码:122 / 128
页数:7
相关论文
共 50 条
  • [31] Genome characteristics of Bordetella pertussis isolates from Tunisia
    Ben Fraj, Ikram
    Bouchez, Valerie
    Smaoui, Hanen
    Kechrid, Amel
    Brisse, Sylvain
    [J]. JOURNAL OF MEDICAL MICROBIOLOGY, 2019, 68 (09) : 1320 - 1323
  • [32] Bordetella pertussis isolates in Finland:: Serotype and fimbrial expression
    Heikkinen, Eriikka
    Xing, Dorothy K.
    Olander, Rose-Marie
    Hytonen, Jukka
    Viljanen, Matti K.
    Mertsola, Jussi
    He, Qiushui
    [J]. BMC MICROBIOLOGY, 2008, 8 (1)
  • [33] Bordetella pertussis isolates in Finland: Serotype and fimbrial expression
    Eriikka Heikkinen
    Dorothy K Xing
    Rose-Marie Ölander
    Jukka Hytönen
    Matti K Viljanen
    Jussi Mertsola
    Qiushui He
    [J]. BMC Microbiology, 8
  • [34] COMPARISON OF HOUSEKEEPING GENES OF BORDETELLA PERTUSSIS IN CLINICAL ISOLATES AND VACCINAL STRAINS BY MEANS OF MLST
    Asadipour, M.
    Noofeli, M.
    Yari, R.
    Samiee, Z.
    [J]. IRANIAN JOURNAL OF PUBLIC HEALTH, 2016, 45 : 34 - 34
  • [35] Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance
    Wilson, KE
    Cassiday, PK
    Popovic, T
    Sanden, GN
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (08) : 2942 - 2944
  • [36] Is Bordetella pertussis susceptibility to erythromycin changing?: MIC trends among Australian isolates 1971-2006
    Sintchenko, Vitali
    Brown, Mitchell
    Gilbert, Gwendolyn L.
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 60 (05) : 1178 - 1179
  • [37] Development of a qualitative assay for screening of Bordetella pertussis isolates for pertussis toxin production
    Gates, Irina
    DuVall, Marina
    Ju, Hong
    Tondella, M. Lucia
    Pawloski, Lucia
    [J]. PLOS ONE, 2017, 12 (04):
  • [38] SEQUENCE VARIATION OF PERTUSSIS TOXIN S1 SUBUNIT GENE IN CLINICAL BORDETELLA PERTUSSIS STRAINS OF IranIAN ISOLATES
    Pour, Marvam Hosein
    Shahcheraghi, Fereshteh
    Nikbin, Vajiheh Sadat
    Ahmadi, Nazanin Jannesar
    [J]. IRANIAN JOURNAL OF PUBLIC HEALTH, 2014, 43 : 25 - 25
  • [39] Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom
    Fry, NK
    Neal, S
    Harrison, TG
    Miller, E
    Matthews, R
    George, RC
    [J]. INFECTION AND IMMUNITY, 2001, 69 (09) : 5520 - 5528
  • [40] ANTIMICROBIAL SUSCEPTIBILITY OF BORDETELLA-PERTUSSIS .1.
    HOPPE, JE
    HAUG, A
    [J]. INFECTION, 1988, 16 (02) : 126 - 130